Retatrutide appears to be a new medication in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By stimulating these https://alexiahgvp851856.ampblogs.com/setmelanotide-a-promising-new-treatment-for-obesity-72920729